Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0348321 (
Haemophilus
)
15,372
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Haemophilus
somnus is a catalase-negative, gram-negative pathogen of cattle which is refractory to killing by bovine neutrophils. In this report, we showed that H. somnus rapidly inhibited
Luminol
-dependent chemiluminescence of bovine neutrophils costimulated with opsonized zymosan or phorbol myristate acetate. We have postulated that this inhibition resulted in part from H. somnus preventing the accumulation of hydrogen peroxide (H2O2) during the oxidative burst. In support of this hypothesis, we have demonstrated that when stimulated with viable H. somnus, bovine neutrophils accumulate lower levels of H2O2 than did neutrophils stimulated with heat-killed H. somnus or opsonized zymosan. We have presented evidence that four separate strains of H. somnus, despite being catalase negative by conventional criteria, removed H2O2 from solution. Viable cells of H. somnus were required for the removal of H2O2 from solution; little or no activity was observed when suspensions of heat-killed, formalin-killed, or sonicated cells of H. somnus were incubated with H2O2. In addition, the elimination of H2O2 occurred only in the presence of carbon sources that could be utilized by H. somnus, indicating that elimination of H2O2 was an energy-dependent process. The amount of H2O2 that could be eliminated by 10(7) cells of H. somnus was greater than 10 nmol, an amount comparable to that produced by a similar number of stimulated bovine neutrophils. Thus, we suggest that the ability of H. somnus to remove H2O2 from solution may be an important virulence mechanism that contributes to the survival of the organism following ingestion by bovine neutrophils.
...
PMID:Elimination of hydrogen peroxide by Haemophilus somnus, a catalase-negative pathogen of cattle. 164 67
Luminol
-enhanced chemiluminescence (CL) of heterologous neutrophils was used to assess the capacity of a 1-ng/ml concentration of
Haemophilus
influenzae type b (Hib)-specific antibodies to induce opsonization of Hib with autologous heat-inactivated sera from children immunized with Hib capsular polysaccharide-polyribosylribitolphosphate (Hib-PRP) conjugate vaccine. Serum samples from 15 of 36 children (42%) vaccinated with Hib-PRP conjugate vaccine had protective levels of Hib-specific antibodies of > or = 1,000 ng/ml. Ten of these 15 (67%) had poor or nonfunctional opsonic activity. Of the 10 children whose sera lacked opsonic activity, 5 (50%) presented with recurrent Hib infection. In contrast, none of the sera of 20 healthy adults lacked opsonic capability. CL intensity was proportional to the concentration of anti-Hib antibodies used for opsonization. Furthermore, the titers of Hib-PRP-specific antibody in children and adults did not correlate with opsonic activity. These results suggest that luminol-enhanced CL as described here with minute concentrations of antibody for opsonization can be used to assess functional capacity of anti-Hib antibodies after vaccination or natural infection in the evaluation of patients with recurrent infections.
...
PMID:A rapid and sensitive chemiluminescence assay for evaluation of functional opsonic activity of Haemophilus influenzae type b-specific antibodies. 766 73